Aytu BioScience (NASDAQ:AYTU) announces
that Tuzistra XR (codeine polistirex and chlorpheniramine polistirex
extended release oral suspension) is now on formulary and covered
nationwide by a leading national pharmacy benefit manager (PBM).
Over 30M commercially-insured patients have now gained access to Tuzistra XR.
https://seekingalpha.com/news/3507178-aytu-bios-tuzistra-xr-now-added-pbms-formulary
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.